drugset / Trial / NCT05962788
Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus Nephritis
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the long-term safety and tolerability of voclosporin for up to an additional 12 months following completion of treatment in the AUR-VCS-2020-03 study (VOCAL) in adolescent and pediatric subjects with lupus nephritis.
Timeline
- Start
- 2024-03-28
- Primary completion
- 2025-07-04
- Completion
- 2025-07-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Voclosporin | Other / unclassified | 15.8 mg | — |
| Subject | Voclosporin | Other / unclassified | 23.7 mg | — |